glp-1 malnutrition & •⁠ ⁠A new review highlights malnutrition as an underrecognized risk of GLP-1 therapy. •⁠ ⁠Appetite suppression can reduce protein, fiber, and micronutrient intake. •⁠ ⁠Lean mass loss, nutrient deficiencies Scurvy — a severe vitamin

Here are a few groups of people who may benefit most from these programs: Individuals with a BMI of 27 or higher who also have weight-related health issues like type 2 diabetes, high blood pressure, or high cholesterol Those struggling with appetite control or frequent cravings, especially when diet and exercise alone havent worked People looking for injections for weight loss who want to avoid or delay bariatric surgery GLP-1 weight loss programs offer a supportive, medication-assisted approach that works best when paired with lifestyle changes

Lanifibranor at the dose required to fix the liver causes weight gain and fluid retention because PPARs are everywhere

Your provider determines which, if either, is appropriate for your specific situation - not the price point or the brand description

Tauopathy: A group of neurodegenerative diseases that arise concomitant with abnormal tau protein deposition in brain cells